ストックスクリーナーアプリを入手
43.74
2.60%
1.11
プレマーケット:
44.00
0.26
+0.59%
前日終値:
$42.63
開ける：
$42.77
24時間の取引高:
733.08K
Relative Volume:
0.71
時価総額：
$2.33B
収益：
$225.21M
当期純損益:
$-15.70M
株価収益率:
-129.18
EPS:
-0.3386
ネットキャッシュフロー:
$-4.78M
1週間 パフォーマンス:
+4.17%
1か月 パフォーマンス:
+27.00%
6か月 パフォーマンス:
+87.08%
1年 パフォーマンス:
+161.13%
1日の値動き範囲:
$41.75
$43.80
1週間の範囲:
$40.34
$43.80
52週間の値動き範囲:
$9.215
$45.83
Axogen Inc Stock (AXGN) Company Profile
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
43.74 | 2.33B | 225.21M | -15.70M | -4.78M | -0.3386 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-19 | 開始されました | Wells Fargo | Overweight |
| 2025-12-01 | 開始されました | Mizuho | Outperform |
| 2025-03-17 | 開始されました | Lake Street | Buy |
| 2024-07-01 | 開始されました | Raymond James | Outperform |
| 2022-11-11 | 再開されました | Jefferies | Buy |
| 2022-05-09 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 開始されました | Guggenheim | Buy |
| 2020-06-16 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-05-07 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-08-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | 開始されました | Canaccord Genuity | Buy |
| 2018-03-02 | 繰り返されました | Lake Street | Buy |
| 2018-01-05 | 再開されました | Cantor Fitzgerald | Overweight |
| 2017-11-30 | 開始されました | Jefferies | Buy |
| 2017-11-21 | 繰り返されました | Lake Street | Buy |
| 2017-07-31 | 開始されました | Leerink Partners | Outperform |
| 2017-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-03-06 | 開始されました | ROTH Capital | Buy |
| 2016-11-22 | アップグレード | Lake Street | Hold → Buy |
| 2016-11-07 | 繰り返されました | Wedbush | Outperform |
| 2016-11-03 | ダウングレード | Lake Street | Buy → Hold |
| 2016-08-04 | 繰り返されました | Wedbush | Outperform |
| 2014-05-14 | 開始されました | Dawson James | Buy |
| 2013-10-31 | 繰り返されました | Ladenburg Thalmann | Buy |
すべてを表示
Axogen Inc (AXGN) 最新ニュース
Axogen outlines at least $270M 2026 revenue on at least 20% growth amid Avance biologic channel transition - MSN
Axogen (AXGN) Is Up 10.3% After Raising 2026 Revenue Outlook Despite Wider Q1 Loss – Has The Bull Case Changed? - simplywall.st
Axogen (AXGN) Q1 2025 Earnings Transcript - AOL.com
AxoGen (NASDAQ:AXGN) Cut to "Hold" at Wall Street Zen - MarketBeat
Axogen, Inc. (NASDAQ:AXGN) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
Axogen, Inc. (NASDAQ:AXGN) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Axogen (AXGN) Q1 2026 Deep Dive: $0.07 EPS, Revenue Up 27% - AlphaStreet
Nerve Repair And Regenerative Market Set to Boom Rapidly, - openPR.com
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference - The Manila Times
Axogen, Inc. (NASDAQ:AXGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$50.78 - simplywall.st
Axogen executives take Bank of America healthcare stage May 13 - Stock Titan
AxoGen Reports Third Quarter 2025 Financial Results and Growth - HarianBasis.co
AXGN Maintained by Canaccord Genuity -- Price Target Raised to $50 - GuruFocus
Vanguard reports 2.66M Axogen stake (NASDAQ: AXGN) - Stock Titan
[ARS] Axogen, Inc. SEC Filing - Stock Titan
FDA win and 20% growth frame Axogen (NASDAQ: AXGN) 2026 pay vote - Stock Titan
AXGN Maintained by Citizens -- Price Target Raised to $50.00 - GuruFocus
AxoGen (NASDAQ:AXGN) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
AXGN Maintained by Wells Fargo -- Price Target Raised to $38.00 - GuruFocus
AxoGen (NASDAQ:AXGN) Price Target Raised to $48.00 at Wells Fargo & Company - MarketBeat
Axogen Q1 2026 revenue up 26.6% to USD 61.5M - Medical Buyer
Citizens raises AxoGen stock price target to $50 on strong sales - Investing.com Australia
AXGN Maintained by HC Wainwright & Co. -- Price Target Raised to $50 - GuruFocus
H.C. Wainwright raises AxoGen stock price target to $50 on revenue beat - Investing.com Nigeria
H.C. Wainwright raises AxoGen stock price target to $50 on revenue beat By Investing.com - Investing.com South Africa
Mizuho raises AxoGen stock price target to $55 on strong growth By Investing.com - Investing.com South Africa
AxoGen Delivers Strong Q1 Growth and Raises 2026 Outlook - The Globe and Mail
Mizuho raises AxoGen stock price target to $55 on strong growth - Investing.com Australia
AxoGen (NASDAQ:AXGN) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Citizens raises AxoGen stock price target to $50 on strong sales By Investing.com - Investing.com South Africa
AxoGen Q1 2026 slides: 27% revenue surge drives stock rally By Investing.com - Investing.com Australia
Axogen Inc (AXGN) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus
Axogen Inc (AXGN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses By GuruFocus - Investing.com Canada
Axogen Inc stock hits 52-week high at 42.32 USD By Investing.com - Investing.com South Africa
Axogen (NASDAQ: AXGN) lifts Q1 revenue 26.6% while fully repaying credit facility - Stock Titan
Axogen (AXGN) Q3 2025 Earnings Transcript - AOL.com
AxoGen Stock Rockets 12% on Q1 2026 Revenue Beat, Raised Guidance and Debt-Free Balance Sheet - International Business Times
Axogen Releases Q1 2026 Financial Results - AlphaStreet
AxoGen, aziende energetiche, Corning - TradingView
AxoGen (AXGN) Q1 earnings lag estimates - MSN
AxoGen Q1 2026 Earnings Call Transcript - MarketBeat
AxoGen (NASDAQ:AXGN) Hits New 1-Year HighHere's Why - MarketBeat
AxoGen (AXGN) Shares Surge 12.8% - GuruFocus
AXGN Stock Climbs As Analysts Hike Price Targets On Coverage Wins - timothysykes.com
Do options traders know something about Axogen stock we don't? - MSN
Axogen Inc (AXGN) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.93%
大文字化:
|
ボリューム (24 時間):